Clinical Trial Update: Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

View source ↗

Summary

A pivotal clinical study is planned to evaluate the accuracy of the IdentiClone Dx TRG Assay for T-Cell Lymphoproliferative Disorder. The study is currently NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoproliferative Disorder

Drugs mentioned

• IdentiClone Dx TRG Assay

Snippet

Sponsor: Invivoscribe, Inc. | Conditions: T-Cell Lymphoproliferative Disorder | Status: NOT_YET_RECRUITING